Delivery Order SPE2DP23D0001-SPE2D626F201V
- Not listed
- The Defense Logistics Agency's Medical Supply Chain division awarded a $2,090.49 delivery order to Canadian Commercial Corporation (CCC) on October 16, 2025, for the procurement of Reactive Skin Decontamination Lotion (RSDL) with an ultimate completion date of January 2, 2026. This delivery order carries no set-aside designation and will be performed at CCC's headquarters in Ottawa, Ontario, Canada. CCC, a Crown corporation owned by the Government of Canada, serves as a prime contractor to...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $2,090.49 to Canadian Commercial Corporation (CCC) on November 6, 2025, for the procurement of Reactive Skin Decontamination Lotion (RSDL). This is a firm fixed-price delivery order with no set-aside designation, with ultimate completion scheduled for January 26, 2026, and performance taking place at CCC's headquarters in Ottawa, Ontario, Canada. As a Crown corporation owned by the Government...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $14,633.43 to Canadian Commercial Corporation (CCC) for Reactive Skin Decontamination Lotion (RSDL) with an ultimate completion date of January 23, 2026. This firm fixed-price delivery order, awarded November 5, 2025, represents a child contract executed against a larger indefinite delivery vehicle. CCC, a Crown corporation owned by the Government of Canada, functions as a government-to-government...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $2,090.49 delivery order to Canadian Commercial Corporation (CCC) on November 16, 2025, for Reactive Skin Decontamination Lotion (RSDL), with an ultimate completion date of February 2, 2026. This delivery order carries no set-aside designation, consistent with CCC's status as a foreign government entity and Crown corporation owned by the Government of Canada. The work will be performed at CCC's headquarters in Ottawa,...
- The U.S. Defense Logistics Agency Medical Supply Chain division awarded a $2,090.49 firm fixed-price delivery order to Canadian Commercial Corporation (CCC) on November 16, 2025, for Reactive Skin Decontamination Lotion (RSDL) with an ultimate completion date of February 2, 2026. The delivery will be performed at CCC's headquarters in Ottawa, Ontario, Canada. This delivery order carries no set-aside designation, consistent with CCC's status as a foreign government entity and Crown corporation...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $35,538.33 firm fixed-price delivery order to Canadian Commercial Corporation (CCC) on November 5, 2025, for the procurement of Reactive Skin Decontamination Lotion (RSDL). The work will be performed in Ottawa, Ontario, Canada, with an ultimate completion date of January 23, 2026. This delivery order carries no set-aside designation, consistent with CCC's role as a Crown corporation operating as a government-to-government...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain division awarded a delivery order valued at $2,090.49 to the Canadian Commercial Corporation (CCC) on October 16, 2025, for the procurement of Reactive Skin Decontamination Lotion (RSDL). This is a firm fixed-price delivery order with no set-aside designation, reflecting CCC's status as a government-to-government contracting entity rather than a small business concern. The work is scheduled for completion by January 2, 2026, with...
- The Defense Logistics Agency Medical Supply Chain division awarded a $2,090.49 delivery order to Canadian Commercial Corporation on November 16, 2025, for Reactive Skin Decontamination Lotion (RSDL). This is a firm fixed-price delivery order with no set-aside designation, reflecting CCC's role as a government-to-government contracting entity rather than a small business concern. The contract is scheduled for completion by February 2, 2026, with performance taking place at CCC's headquarters in...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $2,090.49 delivery order to Canadian Commercial Corporation (CCC) for Reactive Skin Decontamination Lotion (RSDL), a chemical decontamination product used in military medical and hazardous materials response operations. This delivery order, issued on October 22, 2025, with completion scheduled for January 8, 2026, carries no set-aside designation, consistent with CCC's status as a foreign government entity and Crown...
- The U.S. Defense Logistics Agency Medical Supply Chain division awarded a $1,099.24 delivery order to Canadian Commercial Corporation (CCC) on November 3, 2025, for Inactive Skin Decontamination Lotion (RSDL) 21, with performance completion scheduled for January 21, 2026. The work will be performed in Ottawa, Ontario, Canada. This delivery order carries no set-aside designation, consistent with CCC's status as a Crown corporation of the Government of Canada operating as a...
- SPE2DP23D0001Indefinite Delivery Contract
- SPE2DP23D0001-SPE2D626F201VDelivery Order
The Defense Logistics Agency's Medical Supply Chain division awarded a $2,090.49 firm fixed-price delivery order to Canadian Commercial Corporation (CCC) on November 16, 2025, for Reactive Skin Decontamination Lotion (RSDL) with an ultimate completion date of February 2, 2026. This delivery order, designated 4570021266, carries no set-aside designation and will be performed at CCC's headquarters in Ottawa, Ontario, Canada. CCC, a Crown corporation of the Government of Canada, serves as a prime contractor facilitating government-to-government procurement relationships between U.S. defense agencies and Canadian manufacturers, and has maintained active federal contracting status since January 2002. RSDL is a specialized medical decontamination product used by the military for chemical and biological agent neutralization. This delivery order represents one of numerous medical supply procurements CCC has executed for the Defense Logistics Agency's Medical Supply Chain division, alongside related products including Inactive Skin Decontamination Lotion and the MOVES SLC Medical Oxygen System. CCC's extensive federal contract portfolio demonstrates sustained strategic importance to U.S. defense logistics, with hundreds of delivery orders valued in the hundreds of millions of dollars across fiscal years 2025-2026, spanning aviation components, ammunition and propellant products, mechanical assemblies, and specialized equipment across multiple defense agencies including the Army, Navy, Air Force, and Marine Corps.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 11/16/25 |